• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《2019 年冠状病毒病大流行及以后的观察性重症监护研究行为准则:重症监护医学学会发现病毒感染和呼吸道疾病通用研究登记处》。

Guiding Principles for the Conduct of Observational Critical Care Research for Coronavirus Disease 2019 Pandemics and Beyond: The Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study Registry.

机构信息

The Pulmonary Center, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, and Evans Center of Implementation and Improvement Sciences, Department of Medicine, Boston University School of Medicine, Boston, MA.

Department of Health Law, Policy and Management, Boston University School of Public Health, Boston, MA.

出版信息

Crit Care Med. 2020 Nov;48(11):e1038-e1044. doi: 10.1097/CCM.0000000000004572.

DOI:10.1097/CCM.0000000000004572
PMID:32932348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7540620/
Abstract

OBJECTIVES

Use of observational data to inform the response and care of patients during a pandemic faces unique challenges.

DESIGN

The Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study COVID 2019 Registry Core data and research methodology team convened over virtual meetings throughout March to June 2020 to determine best practice goals for development of a pandemic disease registry to support rapid data collection and analysis.

SETTING

International, multi-center registry of hospitalized patients.

PATIENTS

None.

INTERVENTIONS

None.

MEASUREMENTS AND MAIN RESULTS

Large-scale observational data collection requires: 1) quality assurance and harmonization across many sites; 2) a transparent process for selecting from among many potential research questions; 3) the use of best practices in design of descriptive, predictive, and inferential studies; (4) innovative approaches to characterize random error in the setting of constantly updated data; (5) rapid peer-review and reporting; and (6) transitions from a focus on discovery to implementation. Herein, we describe the guiding principles to best practices and suggestions for innovations to study design and reporting within the coronavirus disease 2019 Viral Infection and Respiratory Illness Universal Study pandemic registry.

CONCLUSIONS

Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study coronavirus disease 2019 registry sought to develop and implement prespecified best practices combined with grassroots efforts from clinical sites worldwide in order to develop clinically useful knowledge in response to a pandemic.

摘要

目的

利用观察性数据为大流行期间患者的反应和护理提供信息,这面临着独特的挑战。

设计

重症监护医学会发现病毒感染和呼吸道疾病通用研究 COVID-19 登记核心数据和研究方法团队于 2020 年 3 月至 6 月期间通过虚拟会议召集,以确定制定大流行疾病登记册的最佳实践目标,以支持快速数据收集和分析。

地点

国际多中心住院患者登记处。

患者

无。

干预措施

无。

测量和主要结果

大规模观察性数据收集需要:1)在许多站点之间进行质量保证和协调;2)为从许多潜在研究问题中进行选择制定透明流程;3)在描述性、预测性和推断性研究设计中采用最佳实践;4)在数据不断更新的情况下,创新方法来描述随机误差;5)快速同行评审和报告;6)从专注于发现到实施的转变。在此,我们描述了最佳实践的指导原则,并提出了研究设计和报告方面的创新建议,以适应冠状病毒疾病 2019 病毒感染和呼吸道疾病通用研究大流行登记册。

结论

重症监护医学会发现病毒感染和呼吸道疾病通用研究 COVID-19 登记册旨在制定和实施预先规定的最佳实践,并结合全球临床站点的基层努力,以便针对大流行开发临床有用的知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de0b/7540620/a788b3f1ce8e/ccm-48-e1038-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de0b/7540620/122dc3400740/ccm-48-e1038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de0b/7540620/35099fc4769d/ccm-48-e1038-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de0b/7540620/a788b3f1ce8e/ccm-48-e1038-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de0b/7540620/122dc3400740/ccm-48-e1038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de0b/7540620/35099fc4769d/ccm-48-e1038-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de0b/7540620/a788b3f1ce8e/ccm-48-e1038-g003.jpg

相似文献

1
Guiding Principles for the Conduct of Observational Critical Care Research for Coronavirus Disease 2019 Pandemics and Beyond: The Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study Registry.《2019 年冠状病毒病大流行及以后的观察性重症监护研究行为准则:重症监护医学学会发现病毒感染和呼吸道疾病通用研究登记处》。
Crit Care Med. 2020 Nov;48(11):e1038-e1044. doi: 10.1097/CCM.0000000000004572.
2
Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort (MaastrICCht).连续测量 COVID-19 诱导的急性呼吸疾病以阐明疾病过程的异质性:Maastricht 重症监护 COVID 队列(MaastrICCht)的设计。
BMJ Open. 2020 Sep 29;10(9):e040175. doi: 10.1136/bmjopen-2020-040175.
3
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
4
Principles Guiding Nonpandemic Critical Care Research During a Pandemic.大流行期间指导非大流行危重病研究的原则。
Crit Care Med. 2020 Oct;48(10):1403-1410. doi: 10.1097/CCM.0000000000004538.
5
The EPICENTRE (ESPNIC Covid pEdiatric Neonatal Registry) initiative: background and protocol for the international SARS-CoV-2 infections registry.EPICENTRE(ESPNIC COVID-19 儿科新生儿登记处)倡议:国际 SARS-CoV-2 感染登记处的背景和方案。
Eur J Pediatr. 2020 Aug;179(8):1271-1278. doi: 10.1007/s00431-020-03690-9. Epub 2020 May 22.
6
The Viral Infection and Respiratory Illness Universal Study (VIRUS): An International Registry of Coronavirus 2019-Related Critical Illness.病毒感染与呼吸道疾病通用研究(VIRUS):2019年冠状病毒相关危重症国际登记处。
Crit Care Explor. 2020 Apr 29;2(4):e0113. doi: 10.1097/CCE.0000000000000113. eCollection 2020 Apr.
7
Critical Care for Coronavirus Disease 2019: Perspectives From the PICU to the Medical ICU.《2019 年冠状病毒病的重症监护治疗:从儿科重症监护病房到内科重症监护病房的视角》。
Crit Care Med. 2020 Nov;48(11):1553-1555. doi: 10.1097/CCM.0000000000004543.
8
COVID-19: Mobilizing Quickly for a Rapid Response.新型冠状病毒肺炎:迅速动员以做出快速响应
AACN Adv Crit Care. 2020 Sep 15;31(3):326-333. doi: 10.4037/aacnacc2020366.
9
Coronavirus disease 2019 (COVID-19) in Brasil: information to physical therapists.巴西的2019冠状病毒病(COVID-19):给物理治疗师的信息
Rev Assoc Med Bras (1992). 2020 Apr;66(4):498-501. doi: 10.1590/1806-9282.66.4.498.
10
[Treatment of severe COVID-19 courses in intensive care medicine].[重症监护医学中重症新型冠状病毒肺炎病程的治疗]
Internist (Berl). 2020 Aug;61(8):804-812. doi: 10.1007/s00108-020-00850-9.

引用本文的文献

1
Role of Procalcitonin as a Prognostic Biomarker in Hospitalized COVID-19 Patients: A Comparative Analysis.降钙素原作为住院COVID-19患者预后生物标志物的作用:一项比较分析。
Biomark Insights. 2025 May 15;20:11772719241296624. doi: 10.1177/11772719241296624. eCollection 2025.
2
Antibiotic use patterns and factors associated with leukocyte decrease in COVID-19 patients with suspected secondary infections: A cross-sectional study in Indonesia.新冠肺炎疑似继发感染患者抗生素使用模式及与白细胞减少相关的因素:印度尼西亚的一项横断面研究
Narra J. 2025 Apr;5(1):e2170. doi: 10.52225/narra.v5i1.2170. Epub 2025 Mar 31.
3
The association between early corticosteroid use and the risk of secondary infections in hospitalized patients with COVID-19: a double-edged sword. Results from the international SCCM discovery viral infection and respiratory illness universal study (VIRUS) COVID-19 registry.

本文引用的文献

1
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.撤回:羟氯喹或氯喹联合或不联合大环内酯类药物治疗新型冠状病毒肺炎:一项多国注册分析
Lancet. 2020 May 22. doi: 10.1016/S0140-6736(20)31180-6.
2
The Viral Infection and Respiratory Illness Universal Study (VIRUS): An International Registry of Coronavirus 2019-Related Critical Illness.病毒感染与呼吸道疾病通用研究(VIRUS):2019年冠状病毒相关危重症国际登记处。
Crit Care Explor. 2020 Apr 29;2(4):e0113. doi: 10.1097/CCE.0000000000000113. eCollection 2020 Apr.
3
Clarification of Mortality Rate and Data in Abstract, Results, and Table 2.
早期使用皮质类固醇与COVID-19住院患者继发感染风险之间的关联:一把双刃剑。国际危重病医学会(SCCM)发现病毒感染与呼吸道疾病通用研究(VIRUS)COVID-19登记研究的结果。
Front Med (Lausanne). 2025 Feb 14;12:1466346. doi: 10.3389/fmed.2025.1466346. eCollection 2025.
4
Development of a Core Critical Care Data Dictionary With Common Data Elements to Characterize Critical Illness and Injuries Using a Modified Delphi Method.使用改良德尔菲法开发具有通用数据元素的核心重症监护数据字典,以描述危重病和损伤情况。
Crit Care Med. 2025 May 1;53(5):e1045-e1054. doi: 10.1097/CCM.0000000000006595. Epub 2025 Feb 21.
5
Impact of low dose inhaled nitric oxide treatment in spontaneously breathing and intubated COVID-19 patients: a retrospective propensity-matched study.低剂量吸入一氧化氮治疗有自主呼吸和插管的 COVID-19 患者的影响:一项回顾性倾向评分匹配研究。
Crit Care. 2024 Oct 25;28(1):344. doi: 10.1186/s13054-024-05093-w.
6
Variation in Sedative and Analgesic Use During the COVID-19 Pandemic and Associated Outcomes.2019年冠状病毒病大流行期间镇静和镇痛药物使用的变化及相关结果。
CHEST Crit Care. 2024 Mar;2(1). doi: 10.1016/j.chstcc.2024.100047. Epub 2024 Jan 9.
7
Validation of automated data abstraction for SCCM discovery VIRUS COVID-19 registry: practical EHR export pathways (VIRUS-PEEP).SCCM发现的自动化数据提取在COVID-19病毒登记中的验证:实用的电子健康记录导出途径(VIRUS-PEEP)。
Front Med (Lausanne). 2023 Oct 4;10:1089087. doi: 10.3389/fmed.2023.1089087. eCollection 2023.
8
The Association of Latitude and Altitude with COVID-19 Symptoms: A VIRUS: COVID-19 Registry Analysis.纬度和海拔与新冠病毒症状的关联:一项病毒:新冠病毒注册研究分析
Open Respir Med J. 2022 Aug 31;16:e187430642207130. doi: 10.2174/18743064-v16-e2207130. eCollection 2022.
9
A Path to Real-World Evidence in Critical Care Using Open-Source Data Harmonization Tools.一条利用开源数据协调工具获取重症监护领域真实世界证据的途径。
Crit Care Explor. 2023 Apr 3;5(4):e0893. doi: 10.1097/CCE.0000000000000893. eCollection 2023 Apr.
10
A multisite exploration of the association between critical care implementation factors and clinical outcomes during the COVID-19 pandemic.一项关于新冠疫情期间重症监护实施因素与临床结果之间关联的多中心探索。
J Clin Transl Sci. 2023 Feb 17;7(1):e72. doi: 10.1017/cts.2023.22. eCollection 2023.
摘要、结果及表2中死亡率及数据的说明
JAMA. 2020 May 26;323(20):2098. doi: 10.1001/jama.2020.7681.
4
Drug Evaluation during the Covid-19 Pandemic.新冠疫情期间的药物评估
N Engl J Med. 2020 Jun 11;382(24):2282-2284. doi: 10.1056/NEJMp2009457. Epub 2020 Apr 14.
5
Editorial Concern-Possible Reporting of the Same Patients With COVID-19 in Different Reports.编辑关注——不同报告中可能存在对同一新冠患者的重复报告。
JAMA. 2020 Apr 7;323(13):1256. doi: 10.1001/jama.2020.3980.
6
An interactive web-based dashboard to track COVID-19 in real time.一个基于网络的交互式仪表盘,用于实时追踪新冠病毒。
Lancet Infect Dis. 2020 May;20(5):533-534. doi: 10.1016/S1473-3099(20)30120-1. Epub 2020 Feb 19.
7
Age of Data at the Time of Publication of Contemporary Clinical Trials.出版物发表时的当代临床试验数据年龄。
JAMA Netw Open. 2018 Aug 3;1(4):e181065. doi: 10.1001/jamanetworkopen.2018.1065.
8
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals.因果推断研究中的混杂因素控制与结果报告。呼吸、睡眠和重症监护期刊编辑给作者的指南。
Ann Am Thorac Soc. 2019 Jan;16(1):22-28. doi: 10.1513/AnnalsATS.201808-564PS.
9
Clinical Knowledge from Observational Studies. Everything You Wanted to Know but Were Afraid to Ask.观察性研究中的临床知识。你想知道但又不敢问的一切。
Am J Respir Crit Care Med. 2018 Oct 1;198(7):859-867. doi: 10.1164/rccm.201801-0118PP.
10
An Official American Thoracic Society Research Statement: Implementation Science in Pulmonary, Critical Care, and Sleep Medicine.美国胸科学会官方研究声明:肺部、重症医学和睡眠医学中的实施科学
Am J Respir Crit Care Med. 2016 Oct 15;194(8):1015-1025. doi: 10.1164/rccm.201608-1690ST.